Home / Generic medicine
Generic medicine

Canagliflozin

Canagliflozin · ATC A10BK · Endocrine & metabolic · Antidiabetic medicines

Data statusRegistration & price fields require source verification.
2brand families
7registered presentations
2companies
7with current prices
Available dosage forms

Choose a form

Tap a form to filter the brand list
Tablet7 products Clear form filter ×
Advertisement · clearly labelled sponsored placement
Pakistan brand index

Available brands

One brand is shown once per manufacturer; strengths, forms, packs and DRAP registrations remain visible as separate presentations.
Print / Save PDFAll 7 presentationsFiltered7 presentations
ShareSend this page
2 brands · 7 presentations
Reset
BrandManufacturerRegistered presentations
Canlos4 presentations PHARMEVO (PVT) LTD.
100 mg Tablet 30's 105267 PKR 2,111.012025-08-01 PKR 70.37/ tablet
300 mg Tablet 10's 105266 PKR 1,046.712025-08-04 PKR 104.67/ tablet
300 mg Tablet 14's 105266 PKR 1,465.982025-08-04 PKR 104.71/ tablet
300 mg Tablet 30's 105266 PKR 3,014.052025-08-04 PKR 100.47/ tablet
Nizocan3 presentations Bio-Labs(Pvt) Ltd
300 mg Tablet 10's 104693 PKR 1,071.482026-07-27 PKR 107.15/ tablet
300 mg Tablet 14's 104693 PKR 1,500.682026-07-27 PKR 107.19/ tablet
300 mg Tablet 30's 104693 PKR 3,085.402026-07-27 PKR 102.85/ tablet
Price movement

Official price changes for Canagliflozin

No change in the official DRAP price is recorded yet for any of the 7 tracked presentations (records from 1 Aug 2025).

Independent editorial layer

Medicine information

Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.

Cite this record

Molecule record · ATC A10BK
MedInfoBase. (2026). Canagliflozin — registered brands and price distribution in Pakistan [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/generic/canagliflozin/ ATC A10BK.
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.